// you're reading...

News

Pure Tech Ventures in Boston express interest for innovative new imaging application with IC2

The Boston company, Pure Tech Ventures, express interest for licensing and partnership  for R&D collaboration in the field of medical imaging.

Welcome to ImmunoSigns

ImmunoSigns is a Biotech company founded in 1996. We offer you help in project management and R&D activities within biotechnology and immunodetection.

The core competance of ImmunoSigns is development and production of polyclonal and monoclonal antibodies and design and production of novel immunoassays and diagnostic kits, especially within the clinical area of diabetes and obesity.

Shopping Cart